2014 年 134 巻 5 号 p. 671-677
The adsorption of Bevacizumab, Trastuzumab, Rituximab, Nedaplatin, Vincristine sulfate, Nogitecan hydrochloride, Actinomycin D and Ramosetron hydrochloride to 0.2 μm endotoxin-retentive in-line filters was evaluated with pediatric doses by UV spectrophotometry. The results indicated that some drug adsorption was shown with Nogitecan hydrochloride, Actinomycin D and Ramosetron hydrochloride, and good recovery was shown with the other five drugs. For the three drugs which showed some losses, drug recovery was investigated at multiple test doses. The approximation formula for each drug adsorption was recorded as Y=100−A/X (X: dose (mg), Y: recovery rate (%), A: a constant for individual drug). The results showed there was high correlation between the reciprocal of test drug dose and the recovery rate. Furthermore, in the cases where adsorption to the filter were observed, it was found that it was possible to determine the relationship between dose and the recovery rate from a filterability test with one point pediatric dose. Since the recovery rate obtained from the approximation formula with multiple doses and that calculated from the prediction formula with one point pediatric dose were almost the same, then it was concluded that it is not necessary to conduct the filterability tests with multiple doses. We have shown that using UV spectrophotometry and carrying out a filterability test using one point pediatric dose is relatively easy method and reduces the effort and expense. This method for analysis of drug adsorption is extremely useful when using in-line filters with infusion therapy.